Informação sobre produto
- 1-Piperazinecarboxylic acid, 4-[bis(4-chlorophenyl)methyl]-, 2,5-dioxo-1-pyrrolidinyl ester
- 2,5-Dioxopyrrolidin-1-yl 4-[bis(4-chlorophenyl)methyl]piperazine-1-carboxylate
- MJN 110
MJN110 is a novel drug that inhibits the activity of fatty acid amide hydrolase (FAAH), an enzyme that breaks down anandamide, one of the body's natural endocannabinoids. MJN110 has been shown to have potent antinociceptive and anti-inflammatory effects in animal models. It also has been shown to have beneficial effects on chronic viral hepatitis, as well as other diseases such as type 2 diabetes, neuropathic pain, and Parkinson's disease. MJN110 may be used as an analgesic, anti-inflammatory agent, or agent for treating chronic viral hepatitis.
Propriedades químicas
Consulta técnica sobre: 3D-NHC41621 MJN110
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
